Lupus and pregnancy: Complex yet manageable

Clinical Medicine and Research

Volumn 4, Issue 4, 2006, Pages 310-321

  Dhar, Josephine Patricia ^a,b   Sokol, Robert J ^b,c  

^a HARPER UNIVERSITY HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fetal outcomes; Lupus; Maternal outcomes; Pregnancy; Systemic lupus erythematosus

Indexed keywords

ADALIMUMAB; AZASAN; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETANERCEPT; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG;

ADRENAL SUPPRESSION; AUTOIMMUNE DISEASE; BIRTH DEFECT; BONE MARROW SUPPRESSION; CATARACT; CONGENITAL DISORDER; CONGENITAL MALFORMATION; DEVELOPMENTAL DISORDER; DRUG MECHANISM; ECLAMPSIA; FETUS WASTAGE; HELLP SYNDROME; HUMAN; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MATERNAL HYPERTENSION; OTOTOXICITY; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY DISORDER; PREMATURE LABOR; REVIEW; RISK FACTOR; SIDE EFFECT; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TERATOGENICITY; THROMBOCYTOPENIA;

EID: 33846518262     PISSN: 15394182     EISSN: None     Source Type: Journal    
DOI: 10.3121/cmr.4.4.310     Document Type: Review

References (90)

1. Michet CJ Jr, McKenna CH, Elveback LR, Kaslow RA, Kurland LT. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1985;60:105-113.
2. Hochberg MC. The incidence of systemic lupus erythematosus in Baltimore, Maryland, 1970-1977. Arthritis Rheum 1985;28:80-86.
3. Ward MM, Studenski S. Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences. Arch Intern Med 1990;150:849-853.
4. Hochberg MC, Boyd RE, Ahearn JM, Arnett FC, Bias WB, Provost TT, Stevens MB. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) 1985;64:285-295.
5. Alarcon GS, McGwin G. Jr, Bastian HM, Roseman J, Lisse J, Fessier BJ, Friedman AW, Reveille JD. Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum 2001;45:191-202.
6. Kaslow RA. High rate of death caused by systemic lupus erythematosus among U. S. residents of Asian descent. Arthritis Rheum 1982;25:414-418.
7. Kaslow RA, Masi AT. Age, sex, and race effects on mortality from systemic lupus erythematosus in the United States. Arthritis Rheum 1978;21:473-479.
8. Gordon MF, Stolley PD, Schinnar R. Trends in recent systemic lupus erythematosus mortality rates. Arthritis Rheum 1981;24:762-769.
9. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-1277.
10. O'Neill SG, Schrieber L. Immunotherapy of systemic lupus erythematosus. Autoimmun Rev 2005;4:395-402.
11. Branch DW. Physiologic adaptations of pregnancy. Am J Reprod Immunol 1992;28:120-122.
12. Kitzmiller JL, Stoneburner L, Yelenosky PF, Lucas WE. Serum complement in normal pregnancy and pre-eclampsia. Am J Obstet Gynecol 1973;117:312-315.
13. Baines MG, Millar KG, Mills P. Studies of complement levels in normal human pregnancy. Obstet Gynecol 1974;43:806-810.
14. Burrows RF, Kelton JG. Incidentally detected thrombocytopenia in healthy mothers and their infants. N Engl J Med 1988;319:142-145.
15. Toglia MR, Weg JG. Venous thromboembolism during pregnancy. N Engl J Med 1996;335:108-114.
16. nd ed. New York, NY: McGraw-Hill, 2005.
17. Boumpas DT, Balow JE. Outcome criteria for lupus nephritis trials: a critical overview. Lupus 1998;7:622-629.
18. Carmona F, Font J, Cervera R, Munoz F, Cararach y Balasch J. Obstetrical outcome of pregnancy in patients with systemic Lupus erythematosus. A study of 60 cases. Eur J Obstet Gynecol Reprod Biol 1999;83:137-142.
19. Wong KL, Chan FY, Lee CP. Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study. Arch Intern Med 1991;151:269-273.
20. Dhar JP, Essenmacher LM, Ager JW, Sokol RJ. Pregnancy outcomes before and after a diagnosis of systemic lupus erythematosus. Am J Obstet Gynecol 2005;193:1444-1455.
21. Rahman FZ, Rahman J, Al-Suleiman SA, Rahman MS. Pregnancy outcome in lupus nephropathy. Arch Gynecol Obstet 2005;271:222-226.
22. Egerman RS, Ramsey RD, Kao LW, Bringman JJ, Bush AJ, Wan JY. Hypertensive disease in pregnancies complicated by systemic lupus erythematosus. Am J Obstet Gynecol 2005;193:1676-1679.
23. Wolfberg AJ, Lee-Parritz A, Peller AJ, Lieberman ES. Association of rheumatologic disease with preeclampsia. Obstet Gynecol 2004;103:1190-1193.
24. Yasmeen S, Wilkins EE, Field NT, Sheikh RA, Gilbert WM. Pregnancy outcomes in women with systemic lupus erythematosus. J Matern Fetal Med 2001;10:91-96.
25. Le Thi Thuong D, Tieulie N, Costedoat N, Andreu MR, Wechsler B, Vauthier-Brouzes D, Aumaitre O, Piette JC. The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Ann Rheum Dis 2005;64:273-278.
26. Branch DW, Andres R, Digre KB, Rote NS, Scott JR. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol 1989;73:541-545.
27. Chakravarty EF, Colon I, Langen ES, Nix DA, El-Sayed YY, Genovese MC, Druzin ML. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol 2005;192:1897-1904.
28. Petri M. Hopkins Lupus Pregnancy Center: 1987 to 1996. Rheum Dis Clin North Am 1997;23:1-13.
29. Rahman P, Gladman DD, Urowitz MB. Clinical predictors of fetal outcome in systemic lupus erythematosus. J Rheumatol 1998;25:1526-1530.
30. Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkin's Lupus Pregnancy Center experience. Arthritis Rheum 1991;34:1538-1545.
31. Ruiz-Irastorza G, Lima F, Alves J, Khamashta MA, Simpson J, Hughes GR, Buchanan NM. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol 1996;35:133-138.
32. Lockshin MD, Reinitz E, Druzin ML, Murrman M, Estes D. Lupus pregnancy. Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med 1984;77:893-898
33. Mintz G, Niz J, Gutierrez G, Garcia-Alonso A, Karchmer S. Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J Rheumatol 1986;13:732-739.
34. Urowitz MB, Gladman DD, Farewell VT, Stewart J, McDonald J. Lupus and pregnancy studies. Arthritis Rheum 1993;36:1392-1397.
35. Molad Y, Borkowski T, Monselise A, Ben-Haroush A, Sulkes J, Hod M, Feldberg D, Bar J. Maternal and fetal outcome of lupus pregnancy: a prospective study of 29 pregnancies. Lupus 2005;14:145-151.
36. Buyon JP, Kalunian KC, Ramsey-Goldman R, Petri MA, Lockshin MD, Ruiz-Irastorza G, Khamashta M. Assessing disease activity in SLE patients during pregnancy. Lupus 1999;8:677-684.
37. Abramson SB, Buyon JP. Activation of the complement pathway: comparison of normal pregnancy, preeclampsia, and systemic lupus erythematosus during pregnancy. Am J Reprod Immunol 1992;28:183-187.
38. De Bandt M, Palazzo E, Belmatoug N, M'Bappe R, Hayem G, Kahn MF, Meyer O. Outcome of pregnancies in lupus: experience at one center. Ann Med Interne (Paris) 2000;151:87-92.
39. Rubbert A, Pirner K, Wildt L, Kalden JR, Manger B. Pregnancy course and complications in patients with systemic lupus erythematosus. Am J Reprod Immunol 1992;28:205-207.
40. Rahman P, Gladman DD, Urowitz MB. Clinical predictors of fetal outcome in systemic lupus erythematosus. J Rheumatol 1998;25:1526-1530.
41. Petri M. Pregnancy in SLE. Baillieres Clin Rheumatol 1998;12:449-476.
42. Tincani A, Faden D, Tarantini M, Lojacono A, Tanzi P, Gastaldi A, Di Mario C, Spatola L, Cattaneo R, Balestrieri G. Systemic lupus erythematosus and pregnancy: a prospective study. Clin Exp Rheumatol 1992;10:439-446.
43. Tozman EC, Urowitz MB, Gladman DD. Systemic lupus erythematosus and pregnancy. J Rheumatol 1980;7:624-632.
44. Julkunen H, Jouhikainen T, Kaaja R, Leirisalo-Repo M, Stephansson E, Palosuo T, Teramo K, Friman C. Fetal outcome in lupus pregnancy, a retrospective case-control study of 242 pregnancies in 112 patients. Lupus 1993;2:125-131.
45. Hayslett JP. Maternal and fetal complications in pregnant women with systemic lupus erythematosus. Am J Kidney Dis 1991;17:123-126.
46. Clowse ME, Magder LS, Witter F, Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 2005;52:514-521.
47. Clark CA, Spitzer KA, Nadler JN, Laskin CA. Preterm deliveries in women with systemic lupus erythematosus. J Rheumatol 2003;30:2127-2132.
48. Le Thi Huong D, Wechsler B, Godeau P. Epidemiologic study of pregnancy complicated by lupus. Ann Med Interne (Paris) 1990;141:239-243.
49. Bobrie G, Liote F, Houillier P, Grunfeld JP, Jungers P. Pregnancy in lupus nephritis and related disorders. Am J Kidney Dis 1987;9:339-343.
50. Burkett G. Lupus nephropathy and pregnancy. Clin Obstet Gynecol 1985;28:310-323.
51. Hayslett JP. Effect of pregnancy in patients with SLE. Am J Kidney Dis 1982;2:223-228.
52. Jungers P, Dougados M, Pelissier C, Kuttenn F, Tron F, Lesavre P, Bach JF. Problems posed by pregnancy in women with lupus nephropathy. Presse Med 1983;12:345-349.
53. Cortes-Hernandez J, Ordi-Ros J, Paredes F, Casellas M, Castillo F, Vilardell-Tarres M. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford) 2002;41:643-650.
54. Ramsey-Goldman R, Kutzer JE, Kuller LH, Guzick D, Carpenter AB, Medsger TA Jr. Pregnancy outcome and anti-cardiolipin antibody in women with systemic lupus erythematosus. Am J Epidemiol 1993;138:1057-1069.
55. Germain S, Nelson-Piercy C. Lupus nephritis and renal disease in pregnancy. Lupus 2006;15:148-155.
56. Andersen JC, Dhar P, Essenmacher L, Ager J, Sokol R, Determinants of thrombophilia in an urban systemic lupus erythematosus population. Blood 2005;106 [abstract 4134].
57. Magid MS, Kaplan C, Sammaritano LR, Peterson M, Druzin ML, Lockshin MD. Placental pathology in systemic lupus erythematosus: a prospective study. Am J Obstet Gynecol 1998;179:226-234.
58. Ogishima D, Matsumoto T, Nakamura Y, Yoshida K, Kuwabara Y. Placental pathology in systemic lupus erythematosus with antiphospholipid antibodies. Pathol Int 2000;50:224-229.
59. Moroni G, Ponticelli C. The risk of pregnancy in patients with lupus nephritis. J Nephrol 2003;16:161-167.
60. McGrory CH, McCloskey LJ, DeHoratius RJ, Dunn SR, Moritz MJ, Armenti VT. Pregnancy outcomes in female renal recipients: a comparison of systemic lupus erythematosus with other diagnoses. Am J Transplant 2003;3:35-42.
61. Nossent HC, Swaak TJ. Systemic lupus erythematosus. VI. Analysis of the interrelationship with pregnancy. J Rheumatol 1990;17:771-776.
62. Le Thi Huong D, Wechsler B, Vauthier-Brouzes D, Duhaut P, Costedoat N, Andreu MR, Lefebvre G, Piette JC. The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome. Rheumatology (Oxford) 2006;45:332-338.
63. Witter FR, Petri M. Antenatal detection of intrauterine growth restriction in patients with systemic lupus erythematosus. Int J Gynaecol Obstet 2000;71:67-68.
64. Logghe H, Walker JJ. Towards improved neonatal outcome: future strategies. Semin Fetal Neonatal Med 2004;9:491-498.
65. Buyon JP, Clancy RM. Neonatal lupus: review of proposed pathogenesis and clinical data from the US-based Research Registry for Neonatal Lupus. Autoimmunity 2003;36:41-50.
66. Brucato A, Doria A, Frassi M, Castellino G, Franceschini F, Faden D, Pisoni MP, Solerte L, Muscara M, Lojacono A, Motta M, Cavazzana I, Ghirardello A, Vescovi F, Tombini V, Cimaz R, Gambari PF, Meroni PL, Canesi B, Tincani A. Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. Lupus 2002;11:716-721.
67. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP, Muscara M, Vignati G, Stramba-Badiale M, Catelli L, Lojacono A, Cavazzana I, Ghirardello A, Vescovi F, Gambari PF, Doria A, Meroni PL, Tincani A. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001;44:1832-1835.
68. Buyon JP, Clancy RM. Neonatal lupus: basic research and clinical perspectives. Rheum Dis Clin North Am 2005;31:299-313, vii.
69. Clancy RM, Kapur RP, Molad Y, Askanase AD, Buyon JP. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum 2004;50:173-182.
70. Salomonsson S, Sonesson SE, Ottosson L, Muhallab S, Olsson T, Sunnerhagen M, Kuchroo VK, Thoren P, Herlenius E, Wahren-Herlenius M. Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. J Exp Med 2005;201:11-17.
71. Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, Lee LA, Provost TT, Reichlin M, Rider L, Rupel A, Saleeb S, Weston WL, Skovron ML. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998;31:1658-1666.
72. Sokol RJ, Hutchison P, Krouskop RW, Brown EG, Reed G, Vasquez H. Congenital complete heart block diagnosed during intrauterine fetal monitoring. Am J Obstet Gynecol 1974;120:1115-1117.
73. Bonaminio PN, de Regnier R, Chang E, Day N, Manzi S, Ramsey-Goldman R. Minor physical anomalies are not increased in the offspring of mothers with systemic lupus erythematosus. Ann Rheum Dis 2006;65:246-248.
74. Ostensen M. New insights into sexual functioning and fertility in rheumatic diseases. Best Pract Res Clin Rheumatol 2004;18:219-232.
75. Gordon C. Pregnancy and autoimmune diseases. Best Pract Res Clin Rheumatol 2004;18:359-379.
76. Lowe SA. Diagnostic radiography in pregnancy: risks and reality. Aust N Z J Obstet Gynaecol 2004;44:191-196.
77. Andersen JC, Sagar H, Syed M, Hagood AS, Dhar P. Prothrombotic change in inflammation-inducible coagulation factors identifies thrombotic risk in SLE patients with antiphospholipid antibodies. Blood 2003;102 [abstract 4188].
78. Ruiz-Irastorza G, Khamashta MA, Hughes GR. Systemic lupus erythematosus and antiphospholipid syndrome during pregnancy: maternal and fetal complications and their management. Isr Med Assoc J 2000;2:462-469.
79. Ruiz-Irastorza G, Khamashta MA. Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy. Ann N Y Acad Sci 2005;1051:606-612.
80. Ostensen M, Khamashta M, Lockshin M, Parke A, Brucato A, Carp H, Doria A, Rai R, Meroni P, Cetin I, Derksen R, Branch W, Motta M, Gordon C, Ruiz-Irastorza G, Spinillo A, Friedman D, Cimaz R, Czeizel A, Piette JC, Cervera R, Levy RA, Clementi M, De Carolis S, Petri M, Shoenfeld Y, Faden D, Valesini G, Tincani A. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006;8:209.
81. Petri M. Immunosuppressive drug use in pregnancy. Autoimmunity 2003;36:51-56.
82. Costedoat-Chalumeau N, Amoura Z, Huong DL, Lechat P, Piette JC. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature. Autoimmun Rev 2005;4:111-115.
83. Ross G, Sammaritano L, Nass R, Lockshin M. Effects of mothers' autoimmune disease during pregnancy on learning disabilities and hand preference in their children. Arch Pediatr Adolesc Med 2003;157:397-402.
84. Neri F, Chimini L, Bonomi F, Filippini E, Motta M, Faden D, Lojacono A, Rebaioli CB, Frassi M, Danieli E, Tincani A. Neuropsychological development of children born to patients with systemic lupus erythematosus. Lupus 2004;13:805-811.
85. Clark CA, Spitzer KA, Laskin CA. Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol 2005;32:1709-1712.
86. Chakravarty EF, Nelson L, Krishnan E. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 2006;54:899-907.
87. Ostensen M. Disease specific problems related to drug therapy in pregnancy. Lupus 2004;13:746-750.
88. Borba EF, Turrini-Filho JR, Kuruma KA, Bertola C, Pedalini ME, Lorenzi MC, Bonfa E. Chloroquine gestational use in systemic lupus erythematosus: assessing the risk of child ototoxicity by pure tone audiometry. Lupus 2004;13:223-227.
89. Gordon C, Kilby MD. Use of intravenous immunoglobulin therapy in pregnancy in systemic lupus erythematosus and antiphospholipid antibody syndrome. Lupus 1998;7:429-433.
90. Clowse ME, Magder L, Petri M. Cyclophosphamide for lupus during pregnancy. Lupus 2005;14:593-597.